A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple two-step culture method
- PMID: 20497510
- DOI: 10.1111/j.1537-2995.2010.02706.x
A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple two-step culture method
Abstract
Background: Advances in the past two decades in dendritic cell (DC) biology paved the way to exploit them as a promising tool in cancer immunotherapy. The prerequisite for DC vaccine preparations is large-scale in vitro generations of homogeneous, mature, and functional DCs. Frequent improvements are being made in the existing in vitro DC production protocols to achieve this goal. In our previous study we reported a large-scale generation of mature, functional DCs from umbilical cord blood (UCB) CD34+ cells. Here we report that this method can be used for the efficient generation of DCs from UCB mononuclear cells (MNCs) and thus the hematopoietic stem cell isolation step is not essential.
Study design and methods: MNCs or CD34+ cells isolated from the same cord blood (CB) samples were used for the generation of DCs. DCs were characterized for morphology, phenotype, and functional assays including antigen uptake, chemotaxis, and mixed leukocyte reaction. Similarly DCs generated from the MNCs of same fresh and frozen CB units were compared.
Results: The morphologic, phenotypic, and functional characterization of the DCs generated from various sets show that they were comparable in nature irrespective of the starting population used.
Conclusion: We conclude that the CD34+ isolation step is not essential for the generation of mature, functional DCs and thus can be eliminated. More importantly, we show that DCs can be generated with equal efficiency from the MNCs of frozen CB units. Our culture method will be useful for exploiting the potential of UCB as an additional source for allogeneic DCs in the clinical settings.
© 2010 American Association of Blood Banks.
Similar articles
-
A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells.Transfusion. 2009 Oct;49(10):2109-21. doi: 10.1111/j.1537-2995.2009.02231.x. Epub 2009 May 27. Transfusion. 2009. PMID: 19497054
-
Generation of dendritic cells from fresh and frozen cord blood CD34+ cells.Cryobiology. 1998 Dec;37(4):362-71. doi: 10.1006/cryo.1998.2136. Cryobiology. 1998. PMID: 9917353
-
Dendritic cells can be successfully generated from CD34+ cord blood cells in the presence of autologous cord blood plasma.Bone Marrow Transplant. 2000 Aug;26(4):371-6. doi: 10.1038/sj.bmt.1702525. Bone Marrow Transplant. 2000. PMID: 10982282
-
Cord blood dendritic cells: subsets, functional characteristics and in vitro generation.Leuk Lymphoma. 2003 Jun;44(6):923-8. doi: 10.1080/1042819031000068070. Leuk Lymphoma. 2003. PMID: 12854889 Review.
-
Bags versus flasks: a comparison of cell culture systems for the production of dendritic cell-based immunotherapies.Transfusion. 2018 Jul;58(7):1800-1813. doi: 10.1111/trf.14621. Epub 2018 Apr 19. Transfusion. 2018. PMID: 29672857 Review.
Cited by
-
Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells.J Immunol. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243. Epub 2014 Jul 9. J Immunol. 2014. PMID: 25009205 Free PMC article.
-
Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients.Front Immunol. 2019 May 21;10:1079. doi: 10.3389/fimmu.2019.01079. eCollection 2019. Front Immunol. 2019. PMID: 31164886 Free PMC article.
-
Guidelines for mouse and human DC generation.Eur J Immunol. 2023 Nov;53(11):e2249816. doi: 10.1002/eji.202249816. Epub 2022 Oct 27. Eur J Immunol. 2023. PMID: 36303448 Free PMC article.
-
Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.Stem Cell Res Ther. 2015 Sep 25;6:184. doi: 10.1186/s13287-015-0160-8. Stem Cell Res Ther. 2015. PMID: 26407613 Free PMC article.
-
Differentiated Cells Derived from Hematopoietic Stem Cells and Their Applications in Translational Medicine.Adv Exp Med Biol. 2021;1347:29-43. doi: 10.1007/5584_2021_644. Adv Exp Med Biol. 2021. PMID: 34114129
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous